Lack of association between an estrogen receptor 1 gene polymorphism and Parkinson's disease with dementia

被引:13
作者
Mattila, KM
Rinne, JO
Röyttä, M
Laippala, P
Lehtimäki, T
机构
[1] Tampere Univ Hosp, Ctr Lab Med, Dept Clin Chem, FIN-33521 Tampere, Finland
[2] Univ Tampere, Sch Med, Dept Neurol, FIN-33101 Tampere, Finland
[3] Univ Turku, Turku PET Ctr, Turku, Finland
[4] Univ Turku, Dept Pathol, Turku, Finland
[5] Tampere Univ Hosp, Res Unit, FIN-33521 Tampere, Finland
[6] Univ Tampere, Sch Publ Hlth, FIN-33101 Tampere, Finland
来源
ACTA NEUROLOGICA SCANDINAVICA | 2002年 / 106卷 / 03期
关键词
Parkinson's disease; dementia; estrogen receptor 1; gene; polymorphism;
D O I
10.1034/j.1600-0404.2002.01331.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective - To test for an association between an estrogen receptor 1 (ESR1 ) gene polymorphism and Parkinson's disease with dementia (PDD) in Finnish subjects. Subjects and methods - Forty-one clinically demented and pathologically confirmed PDD patients and 59 cognitively intact aged individuals with normal neuropathology were genotyped for the ESR1 Pvu II polymorphism. Results - We found no significant differences in the genotype or allele frequencies when the PDD patients were compared with the controls. Nor were there any significant differences in these frequencies when the PDD patients with coexisting Alzheimer's disease pathology were compared with the control group. Conclusion - We failed to demonstrate an association between dementia-associated PD and the ESR1 Pvu II polymorphism in Finnish subjects.
引用
收藏
页码:128 / 130
页数:3
相关论文
共 11 条
[1]  
Checkoway H, 1998, NEUROTOXICOLOGY, V19, P635
[2]  
de Silva HA, 2000, CURR OPIN GENET DEV, V10, P292
[3]   ACCURACY OF CLINICAL-DIAGNOSIS OF IDIOPATHIC PARKINSONS-DISEASE - A CLINICOPATHOLOGICAL STUDY OF 100 CASES [J].
HUGHES, AJ ;
DANIEL, SE ;
KILFORD, L ;
LEES, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1992, 55 (03) :181-184
[4]  
ISOE K, 1997, ALZHEIMERS RES, V3, P195
[5]   Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia [J].
Isoe-Wada, K ;
Maeda, M ;
Yong, J ;
Adachi, Y ;
Harada, H ;
Urakami, K ;
Nakashima, K .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (04) :431-435
[6]  
Kompoliti K, 1999, CLIN NEUROPHARMACOL, V22, P318
[7]   Interaction between estrogen receptor 1 and the ε4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women [J].
Mattila, KM ;
Axelman, K ;
Rinne, JO ;
Blomberg, M ;
Lehtimäki, T ;
Laippala, P ;
Röyttä, M ;
Viitanen, M ;
Wahlund, LO ;
Winblad, B ;
Lannfelt, L .
NEUROSCIENCE LETTERS, 2000, 282 (1-2) :45-48
[8]   Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease [J].
Mattila, PM ;
Röyttä, M ;
Torikka, H ;
Dickson, DW ;
Rinne, JO .
ACTA NEUROPATHOLOGICA, 1998, 95 (06) :576-582
[9]   THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .2. STANDARDIZATION OF THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMERS-DISEASE [J].
MIRRA, SS ;
HEYMAN, A ;
MCKEEL, D ;
SUMI, SM ;
CRAIN, BJ ;
BROWNLEE, LM ;
VOGEL, FS ;
HUGHES, JP ;
VANBELLE, G ;
BERG, L .
NEUROLOGY, 1991, 41 (04) :479-486
[10]  
Schneider S., 2000, ARLEQUIN VER 2000 SO